Patents by Inventor Anis Khurso Mir

Anis Khurso Mir has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nogo-A binding molecules and pharmaceutical use thereof
    Patent number: 8758754
    Abstract: The present invention provides a binding molecule which is capable of binding to the human NogoA polypeptide or human NiG with a dissociation constant <1000 nM, a polynucleotide encoding such binding molecule; an expression vector comprising said polynucleotide; an expression system comprising a polynucleotide capable of producing a binding molecule; an isolated host cell which comprises an expression system as defined above; the use of such binding molecule as a pharmaceutical, especially in the treatment of a disease of the peripheral (PNS) and/or central (CNS) nervous system; a pharmaceutical composition comprising said binding molecule; and a method of treatment of a disease of the peripheral (PNS) and/or central (CNS) nervous system.
    Type: Grant
    Filed: March 16, 2012
    Date of Patent: June 24, 2014
    Assignee: Novartis AG
    Inventors: Carmen Barske, Stefan Frentzel, Anis Khurso Mir, Martin E. Schwab, Alessandra Vitaliti Garami
  • NOGO-A BINDING MOLECULES AND PHARMACEUTICAL USE THEREOF
    Publication number: 20110027284
    Abstract: The present invention provides a binding molecule which is capable of binding to the human NogoA polypeptide or human NiG with a dissociation constant<1000 nM, a polynucleotide encoding such binding molecule; an expression vector comprising said polynucleotide; an expression system comprising a polynucleotide capable of producing a binding molecule; an isolated host cell which comprises an expression system as defined above; the use of such binding molecule as a pharmaceutical, especially in the treatment of a disease of the peripheral (PNS) and/or central (CNS) nervous system; a pharmaceutical composition comprising said binding molecule; and a method of treatment of a disease of the peripheral (PNS) and/or central (CNS) nervous system.
    Type: Application
    Filed: October 27, 2008
    Publication date: February 3, 2011
    Applicants: NOVARTIS AG, UNIVERSITY OF ZURICH
    Inventors: Carmen Barske, Stefan Frentzel, Anis Khurso Mir, Martin E. Schwab, Alessandra Vitaliti